Methods and compositions for the treatment of cancer

Details for Australian Patent Application No. 2009294618 (hide)

Owner TRASLATIONAL CANCER DRUGS PHARMA, S.L.

Inventors Ramirez De Molina, Ana; Garcia Oroz, Lourdes; Lacal Sanjuan, Juan Carlos

Agent Collison & Co

Pub. Number AU-A-2009294618

PCT Pub. Number WO2010/031825

Priority 08380270.2 17.09.08 EP

Filing date 17 September 2009

Wipo publication date 25 March 2010

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

C12Q 1/34 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

Event Publications

14 April 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 18 Mar 2011

14 April 2011 PCT application entered the National Phase

  PCT publication WO2010/031825 Priority application(s): WO2010/031825

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009294622-Synergistic combinations of a macrocyclic inhibitor of HCV and a nucleoside

2009294613-Glucoside derivatives and uses thereof as SGLT inhibitors